Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:14 PM
Ignite Modification Date:
2025-12-24 @ 1:14 PM
NCT ID:
NCT00240695
Eligibility Criteria:
Inclusion Criteria:
* Completed 24 months of double-blind treatment in 1 of 2 previous studies with galantamine without progressing to dementia (CDR\< 1)
* Able to safely receive open-label galantamine in the opinion of the investigator and treatment is in the individual's best interest
* Regular (at least 3 days a week) visits from a person able to accompany patient to scheduled visits
* Enrolled within 7-30 days after the previous galantamine study Exclusion Criteria:
* Individuals who converted to dementia (CDR \> = 1) during 1 of the previous galantamine studies
* Prematurely discontinued 1 of the previous galantamine studies or completed 1 of the previous studies more than 30 days prior to this study
* Current clinically significant cardiovascular disease (including heart surgery, unstable angina, congestive heart failure, fibrillation, valve disease or uncontrolled high blood pressure)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT00240695
Study Brief:
Protocol Section:
NCT00240695